To define how immunologic networks are perturbed by B cell depletion therapy
Latest Information Update: 07 Apr 2022
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics; Pharmacogenomic
Most Recent Events
- 07 Apr 2022 New trial record
- 26 Feb 2022 Results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2022